Phase 2 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been newly diagnosed with a specific type of lymphoma called Double Expression Diffuse Large B-cell Lymphoma
- People aged between 18 and 70 years old
- People whose general health and ability to perform daily activities falls within an acceptable range (a score of 0–2 on a standard medical scale — confirm with trial site)
- People whose lymphoma has been classified at a certain stage of spread (Stage II, III, or IV — confirm with trial site)
- People whose blood and body test results meet the laboratory standards required by the trial
- People who are expected to live for at least 3 months
Who may not be able to join:
- People whose lymphoma has spread to the brain or spinal cord (central nervous system)
- People with uncontrolled heart, blood vessel, or brain circulation problems, blood clotting disorders, or connective tissue diseases
- People with uncontrolled infections, including hepatitis B, hepatitis C, or HIV/AIDS
- People who are being considered for or are planning to have a stem cell or organ transplant
- People who are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: zengjun Li, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences
Phone: 13642138692
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
complete response rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.